The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Oct. 02, 2018
Filed:
Jan. 08, 2014
Applicant:
Pathologica Llc, San Francisco, CA (US);
Inventors:
Jeremy Blitzer, San Francisco, CA (US);
John McKearn, Saint Louis, MO (US);
Assignee:
Pathologica LLC, San Francisco, CA (US);
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/15 (2006.01); A61K 31/137 (2006.01); A61K 38/03 (2006.01); A61K 38/21 (2006.01); A61K 31/136 (2006.01); A61K 31/155 (2006.01); A61K 31/225 (2006.01); A61K 31/277 (2006.01); A61K 31/4704 (2006.01); A61K 9/00 (2006.01);
U.S. Cl.
CPC ...
A61K 31/15 (2013.01); A61K 9/0053 (2013.01); A61K 31/136 (2013.01); A61K 31/137 (2013.01); A61K 31/155 (2013.01); A61K 31/225 (2013.01); A61K 31/277 (2013.01); A61K 31/4704 (2013.01); A61K 38/03 (2013.01); A61K 38/21 (2013.01);
Abstract
Disclosed herein are new oral pharmaceutical compositions of SAMDC inhibitors, polyamine analogs, and polyamine biosynthesis inhibitors, and their application for the treatment of conditions including demyelinating diseases, autoimmune disorders affecting the nervous system, and other neurodegenerative conditions.